Liu Haifeng
Tracked across 1 events · 6 articles · First seen Jun 03, 2026 · Last active Jun 03, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Sichuan Kelun-Biotech Biopharmaceutical announced the positive first-in-human study results for its novel B7-H3 ADC SKB500 at the 2026 American Society of Clinical Oncology Annual Meeting in Chicago, United States. Professor Liu Haifeng from Jilin Provincial…
Impact: Professor Liu Haifeng, the Principal Investigator from Jilin Provincial Cancer Hospital, presented the positive study results of SKB500, highlighting its therapeutic potential.
Jun 03, 2026 · 6 articles
80
Liu Haifeng presented study dataSichuan Kelun-Biotech...
NEWSDESK
Track Liu Haifeng live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard